Sigachi Industries Limited (NSE:SIGACHI)
38.91
+0.33 (0.86%)
Oct 23, 2025, 3:30 PM IST
Sigachi Industries Revenue
Sigachi Industries had revenue of 1.28B INR in the quarter ending June 30, 2025, with 33.99% growth. This brings the company's revenue in the last twelve months to 5.21B, up 27.03% year-over-year. In the fiscal year ending March 31, 2025, Sigachi Industries had annual revenue of 5.00B with 23.81% growth.
Revenue (ttm)
5.21B
Revenue Growth
+27.03%
P/S Ratio
2.86
Revenue / Employee
3.46M
Employees
1,507
Market Cap
14.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 5.00B | 962.25M | 23.81% |
Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
Mar 31, 2021 | 1.96B | 530.96M | 37.21% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Aurobindo Pharma | 320.25B |
Cipla | 274.80B |
Zydus Lifesciences | 236.08B |
Apollo Hospitals Enterprise | 225.51B |
Glenmark Pharmaceuticals | 134.56B |
Alkem Laboratories | 133.04B |
Mankind Pharma | 129.10B |